1. Grant JE, Odlaug BL, Chamberlain SR. Gambling disorder, DSM-5 criteria and symptom severity. Compr Psychiatry. 2017;75:1–5. 2. Black DW, Shaw MC, Allen J. Extended release carbamazepine in the treatment… Click to show full abstract
1. Grant JE, Odlaug BL, Chamberlain SR. Gambling disorder, DSM-5 criteria and symptom severity. Compr Psychiatry. 2017;75:1–5. 2. Black DW, Shaw MC, Allen J. Extended release carbamazepine in the treatment of pathological gambling: an open-label study. Prog neuro-psychopharmacology Biol Psychiatry. 2008;32:1191–1194. 3. Dannon PN, Lowengrub K, Gonopolski Y, et al. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacology. 2005;28:6–10. 4. Dannon PN, Lowengrub K, Musin E, et al. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. J Clin Psychopharmacol. 2007;27:620–624. 5. Pallanti S, Quercioli L, Sood E, et al. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry. 2002;63:559– 564. 6. Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. New Engl J Med. 2011;364:1126–1133. 7. Di Stefano G, La Cesa S, Truini A, et al. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain. 2014;15:34. 8. Mathar D, Wiehler A, Chakroun K, et al. A potential link between gambling addiction severity and central dopamine levels: evidence from spontaneous eye blink rates. Scientific Rep. 2018;8:13371. 9. Joca SR, Skalisz LL, Beijamini V, et al. The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission. Eur Neuropsychopharmacol. 2000;10:223–228. 10. Guerreiro CAM, Guerreirol MM. Carbamazepine and oxcarbazepine. In: Wyllie E, ed. Wyllie’s Treatment of Epilepsy, Principles and Practice 5th ed Philadelphia, PA: Lippincott Williams and Wilkins; 2011: 614–621. 11. Tremblay M, Winstanley CA. Anticonvulsant medications attenuate amphetamine-induced deficits in behavioral inhibition but not decision making under risk on a rat gambling task. Behav Brain Res. 2016;314:143–151. 12. Hodgins DC, Holub A. Components of impulsivity in gambling disorder. Int J Ment Health Addict. 2015;13: 699–711.
               
Click one of the above tabs to view related content.